Kirkland, Dechert Advise as Bristol-Myers Squibb Acquires Inhibitex for $2.5 Billion
Kirkland advises Bristol-Myers Squibb in a $2.5 billion acquisition deal with Inhibitex, Inc.
To read the full text of this article, please click here.
Kirkland advises Bristol-Myers Squibb in a $2.5 billion acquisition deal with Inhibitex, Inc.
To read the full text of this article, please click here.
